Chinook Therapeutics Inc Cvr (ADRO)

CapEx to Revenue

7.30%

TTM · Retrieved:

ADRO logo

ADRO CapEx to Revenue

Current (TTM)7.30%
ADRO CapEx/Revenue (20.53% → 7.30%)
High-resolution chart · PNG

ADRO capex to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Chinook Therapeutics Inc Cvr CapEx to Revenue — Annual fiscal periods
Period endingCapEx to Revenue
7.301%
15.6757%
29.8973%
47.1321%
2.9789%
5.8406%
20.5314%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.